1. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. Issue 5 (May 2022) Authors: Tamborlane, William V; Laffel, Lori M; Shehadeh, Naim; Isganaitis, Elvira; Van Name, Michelle; Ratnayake, Jayantha; Karlsson, Cecilia; Norjavaara, Ensio Journal: Lancet Issue: Volume 10:Issue 5(2022) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗